ROSSI DINO A (CIK 1209059) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Sell KRYS (3,691 shares), Sell KRYS (341 shares), Sell KRYS (2,287 shares), Sell KRYS (5,226 shares), Sell KRYS (1,687 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 3,691 | $0 |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 341 | $111,029 |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 2,287 | $746,941 |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 5,226 | $1.7M |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 1,687 | $554,205 |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 7,428 | $2.4M |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 4,896 | $1.6M |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 3,095 | $1.0M |
| 2026-08-14 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 40 | $13,329 |
| 2026-02-23 | Krystal Biotech, Inc. (KRYS) | Director | Buy | 18,950 | $166,570 |
| 2026-02-23 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 8,116 | $2.1M |
| 2026-02-23 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 10,834 | $2.8M |
Source: SEC Form 4 filings · as of 2026-08-14